Successful Treatment Using Apixaban in a Patient on Hemodialysis with Uremic Calciphylaxis

1Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Calciphylaxis is a rare but serious condition in which microvessel occlusion occurs within the subcutaneous adipose tissue and dermis, leading to painful lesions. End-stage renal disease requiring hemodialysis and warfarin therapy can increase the risk of calciphylaxis. In this report, we describe the evaluation and treatment of a 75-year-old female patient with warfarin-induced calciphylaxis who presented unique symptoms. The patient required intensive care unit admission due to hemodynamic instability, which was treated with inotropes and broad-spectrum intravenous antibiotics. This description of the patient’s unusual symptoms has the potential to provide insights needed to improve the diagnosis of future patients. Due to the unavailability of FDA-approved treatment for calciphylaxis, its management is based on data from observational studies and clinical experience.

Cite

CITATION STYLE

APA

Alasmari, M. M., Alsheikh, M. Y., & Metwali, H. H. (2022). Successful Treatment Using Apixaban in a Patient on Hemodialysis with Uremic Calciphylaxis. Clinical, Cosmetic and Investigational Dermatology, 15, 2329–2333. https://doi.org/10.2147/CCID.S382503

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free